Celcuity Overview

  • Founded
  • 2011
Founded
  • Status
  • Public
  • Employees
  • 30
Employees
  • Stock Symbol
  • CELC
Stock Symbol
  • Share Price
  • $13.01
  • (As of Friday Closing)

Celcuity General Information

Description

Celcuity Inc is active in the healthcare domain. It is a cellular analysis company that is discovering new cancer sub-types and commercialising diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The company's proprietary CELx diagnostic platform uses the patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Stock Exchange
NAS
Primary Office
  • 16305 – 36th Avenue North
  • Suite 450
  • Minneapolis, MN 55446
  • United States
+1 (763) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Celcuity Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$13.01 $14.44 $8.75 - $33.01 $215M 14.9M 46.5K -$2.03

Celcuity Financials Summary

In Thousands,
USD
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 241,048 80,936 88,924 220,983
Revenue 0 0 0 0
EBITDA (24,249) (9,171) (7,466) (7,707)
Net Income (25,403) (9,474) (7,359) (7,481)
Total Assets 91,838 12,957 20,281 26,032
Total Debt 14,737 262 256 26
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Celcuity Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Celcuity‘s full profile, request access.

Request a free trial

Celcuity Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Celcuity Inc is active in the healthcare domain. It is a cellular analysis company that is discovering new cancer sub-ty
Biotechnology
Minneapolis, MN
30 As of 2020
000.00
000000000 - 000.00

0000000

m, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irur
0000000000000
Charleston, SC
00 As of 0000
00.000
0000000000.

000000

re magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip
0000000000000
Freiburg, Germany
00 As of 0000
00.00
00.00 0000-00-00
000000&0 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Celcuity Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Iverson Genetic Diagnostics Formerly Angel backed Charleston, SC 00 00.000 0000000000.
000000 Formerly VC-backed Freiburg, Germany 00 00.00 000000&0 00.00
0000000 0000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
000000 Venture Capital-Backed Minneapolis, MN 00 00.000 0000000000 0 00.000
00000000 00 Corporate Backed or Acquired Cambridge, United Kingdom 00 00000 00000000
You’re viewing 5 of 10 competitors. Get the full list »

Celcuity Patents

Celcuity Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3365436-B1 Methods of preparing a primary cell sample Active 20-Oct-2015 0000000000
EP-3365436-A1 Methods of preparing a primary cell sample Granted 20-Oct-2015 0000000000
CA-2999054-A1 Methods of preparing a primary cell sample Pending 20-Oct-2015 0000000000
US-20180230434-A1 Methods of preparing a primary cell sample Pending 20-Oct-2015 0000000000
JP-2018531021-A Methods for preparing primary cell samples Pending 20-Oct-2015 C12N5/0693

Celcuity Executive Team (5)

Name Title Board Seat Contact Info
Brian Sullivan Chief Executive Officer & Chairman
Vicky Hahne Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Lance Laing Ph.D Chief Scientific Officer & Founder
You’re viewing 3 of 5 executive team members. Get the full list »

Celcuity Board Members (5)

Name Representing Role Since
Brian Sullivan Celcuity Chief Executive Officer & Chairman 000 0000
David Dalvey Self Board Member 000 0000
Richard Nigon Jr. Cedar Point Capital Board Member 000 0000
You’re viewing 3 of 5 board members. Get the full list »

Celcuity Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Celcuity Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Celcuity‘s full profile, request access.

Request a free trial